Rini, B. I., Halabi, S., Rosenberg, J. E., Stadler, W. M., Vaena, D. A., Ou, S., . . . Small, E. J. (2008). Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206. American Society of Clinical Oncology.
استشهاد بنمط شيكاغوRini, Brian I., et al. Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206. American Society of Clinical Oncology, 2008.
MLA استشهادRini, Brian I., et al. Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206. American Society of Clinical Oncology, 2008.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.